C21 · Pharmaceuticals · US
Pharmaceutical R&D investment in United States
United States: 125,986 million USD (pharmaceutical and medicine manufacturing total R&D performance, 2023), +8.5% on 2022.
- 125,986 million USD Latest · 2023
- +8.5% vs 2022
- 8Records · 7 measures
Annual · 2 publishers · Next period 2024
Pharmaceutical and medicine manufacturing total R&D performance in United States
Pharmaceutical and medicine manufacturing total R&D performance
United States, 2022 to 2023
Every record
8 records across 7 measures, newest first within each. Each period opens its record and quote.
| Measure | Period | Value | Source |
|---|---|---|---|
| Health sector research and development investment growth rate | 2024 | 7.1% | European Commission |
| Pharmaceutical and medicine manufacturing company-funded R&D | 2023 | 114,225 million USD | NCSES |
| Pharmaceutical and medicine manufacturing externally funded R&D | 2023 | 11,761 million USD | NCSES |
| Pharmaceutical and medicine manufacturing R&D funded by domestic companies | 2023 | 2,104 million USD | NCSES |
| Pharmaceutical and medicine manufacturing R&D funded by foreign companies | 2023 | 9 billion USD | NCSES |
| Pharmaceutical and medicine manufacturing R&D funded by other external sources | 2023 | 79 million USD | NCSES |
| Pharmaceutical and medicine manufacturing total R&D performance | 2023 | 125,986 million USD | NCSES |
| Pharmaceutical and medicine manufacturing total R&D performance | 2022 | 116,073 million USD | NCSES |
Frequently asked questions
What is the latest pharmaceutical R&D investment figure for United States?
United States: 125,986 million USD pharmaceutical and medicine manufacturing total R&D performance in 2023, +8.5% on 2022.
Where does the United States data come from?
8 records from 3 documents by European Commission, NCSES. Each figure links to its record and the sentence it was read from.
Cite this page
Free to reuse under CC BY 4.0 with attribution to StatOrigin and the original publisher.
StatOrigin. (2026). Pharmaceutical R&D investment in United States [Data set]. Retrieved September 29, 2026, from https://statorigin.org/statistics/pharmaceutical-r-and-d-investment/united-states
"Pharmaceutical R&D investment in United States." StatOrigin, 2026, https://statorigin.org/statistics/pharmaceutical-r-and-d-investment/united-states. Accessed 29 Sep. 2026.
StatOrigin. "Pharmaceutical R&D investment in United States." Data set, 2026. Accessed September 29, 2026. https://statorigin.org/statistics/pharmaceutical-r-and-d-investment/united-states.
@misc{statorigin_pharmaceutical_r_and_d_investment_united_states_2026, title = {Pharmaceutical R\&D investment in United States}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/pharmaceutical-r-and-d-investment/united-states}, note = {Data set. Accessed 2026-09-29} }